CAG
LLY icon

Centerpoint Advisory Group’s Eli Lilly LLY Stock Holding History

Centerpoint Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Sell
370
-3
-0.8% -$3.04K 0.26% 74
2025
Q4 		$401K Hold
373
– – 0.31% 65
2025
Q3 		$285K Hold
373
– – 0.22% 79
2025
Q2 		$291K Sell
373
-287
-43% -$223K 0.25% 76
2025
Q1 		$545K Sell
660
-6
-0.9% -$4.99K 0.54% 49
2024
Q4 		$514K Buy
+666
New +$551K 0.5% 51

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Centerpoint Advisory Group's LLY Position: Q1 2026 in Review

Centerpoint Advisory Group reduced its Eli Lilly (LLY) stake by 0.8% in Q1 2026, selling an estimated $3.04K and leaving 370 shares worth $340K. The position accounts for 0.26% of the portfolio, ranked #74.

Centerpoint Advisory Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $545K in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Centerpoint Advisory Group held 370 shares of Eli Lilly worth $340K as of Q1 2026.
  • Centerpoint Advisory Group sold 3 Eli Lilly shares in Q1 2026, an estimated $3.04K.
  • Eli Lilly made up 0.26% of Centerpoint Advisory Group's portfolio in Q1 2026, its #74 holding.
  • Centerpoint Advisory Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Centerpoint Advisory Group's Eli Lilly position peaked at $545K in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Centerpoint Advisory Group's 13F filing for Q1 2026, filed 29 Apr 2026.